Since NP references Gilead, I thought I will dig a little on the share price history and milestones as a reference to that story. Could cydy repeat? It would take a series of successful approvals like Gilead had in my opinion: combo approval, mono approval, tnbc approval, ccr5+ cancer approval, all metastatic cancers approval, gvhd approval, etc.